The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Menorrhagia


High impact information on Menorrhagia


Chemical compound and disease context of Menorrhagia


Biological context of Menorrhagia


Anatomical context of Menorrhagia


Gene context of Menorrhagia


Analytical, diagnostic and therapeutic context of Menorrhagia


  1. Oestrogen deficiency after tubal ligation. Cattanach, J. Lancet (1985) [Pubmed]
  2. Symptomatic vitamin E deficiency diagnosed after histological recognition of myometrial lipofuscinosis. Evans, D.J., Berney, D.M., Pollock, D.J. Lancet (1995) [Pubmed]
  3. Cerebral sinus thrombosis as a potential hazard of antifibrinolytic treatment in menorrhagia. Achiron, A., Gornish, M., Melamed, E. Stroke (1990) [Pubmed]
  4. von Willebrand's disease diagnosed after menorrhagia worsened from levonorgestrel intrauterine system. Lukes, A.S., Perry, S., Ortel, T.L. Obstetrics and gynecology. (2005) [Pubmed]
  5. Effects of progesterone on uterine leiomyoma growth and apoptosis. Maruo, T., Matsuo, H., Samoto, T., Shimomura, Y., Kurachi, O., Gao, Z., Wang, Y., Spitz, I.M., Johansson, E. Steroids (2000) [Pubmed]
  6. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Hurskainen, R., Teperi, J., Rissanen, P., Aalto, A.M., Grenman, S., Kivelä, A., Kujansuu, E., Vuorma, S., Yliskoski, M., Paavonen, J. Lancet (2001) [Pubmed]
  7. Hypermenorrhea associated with ritonavir. Nielsen, H. Lancet (1999) [Pubmed]
  8. Can nifedipine provoke menorrhagia? Rodger, J.C., Torrance, T.C. Lancet (1983) [Pubmed]
  9. Naproxen in menorrhagia. Rybo, G., Nilsson, S., Sikström, B., Nygren, K.G. Lancet (1981) [Pubmed]
  10. Ethamsylate in treatment of menorrhagia. Kasonde, J.M. Lancet (1976) [Pubmed]
  11. Tranexamic acid: a review of its use in the management of menorrhagia. Wellington, K., Wagstaff, A.J. Drugs (2003) [Pubmed]
  12. Benefits and risks of pharmacological agents used for the treatment of menorrhagia. Roy, S.N., Bhattacharya, S. Drug safety : an international journal of medical toxicology and drug experience. (2004) [Pubmed]
  13. Assessment of medical treatments for menorrhagia. Shaw, R.W. British journal of obstetrics and gynaecology. (1994) [Pubmed]
  14. Effectiveness and mechanism of action of desmopressin in the treatment of copper intrauterine device-related menorrhagia: a pilot study. Mercorio, F., De Simone, R., Di Carlo, C., Bifulco, G., Tessitore, G., Di Spiezio Sardo, A., Nappi, C. Hum. Reprod. (2003) [Pubmed]
  15. Menorrhagia associated with laboratory abnormalities of hemostasis: epidemiological, diagnostic and therapeutic aspects. Kouides, P.A., Kadir, R.A. J. Thromb. Haemost. (2007) [Pubmed]
  16. Down-regulation of angiopoietin-1 expression in menorrhagia. Hewett, P., Nijjar, S., Shams, M., Morgan, S., Gupta, J., Ahmed, A. Am. J. Pathol. (2002) [Pubmed]
  17. Fibroblast growth factor receptor-1 is a critical component for endometrial remodeling: localization and expression of basic fibroblast growth factor and FGF-R1 in human endometrium during the menstrual cycle and decreased FGF-R1 expression in menorrhagia. Sangha, R.K., Li, X.F., Shams, M., Ahmed, A. Lab. Invest. (1997) [Pubmed]
  18. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia. Gleeson, N.C. Am. J. Obstet. Gynecol. (1994) [Pubmed]
  19. Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. van Eijkeren, M.A., Christiaens, G.C., Geuze, H.J., Haspels, A.A., Sixma, J.J. Am. J. Obstet. Gynecol. (1992) [Pubmed]
  20. Screening and diagnosis of coagulation disorders. Lusher, J.M. Am. J. Obstet. Gynecol. (1996) [Pubmed]
  21. Endometrial vascular smooth muscle oestrogen and progesterone receptor distribution in women with and without menorrhagia. Rogers, P.A., Lederman, F., Kooy, J., Taylor, N.H., Healy, D.L. Hum. Reprod. (1996) [Pubmed]
  22. The role of prostaglandins and allied substances in uterine haemostasis. Hagenfeldt, K. Contraception. (1987) [Pubmed]
  23. Use of goserelin depot, a gonadotropin-releasing hormone agonist, for the treatment of menorrhagia and severe anemia in women with leiomyomata uteri. Candiani, G.B., Vercellini, P., Fedele, L., Arcaini, L., Bianchi, S., Candiani, M. Acta obstetricia et gynecologica Scandinavica. (1990) [Pubmed]
  24. Vasopressin and prolactin as stress hormones. Punnonen, R., Teisala, K., Häkkinen, V., Viinamäki, O., Pystynen, P. Gynecol. Obstet. Invest. (1986) [Pubmed]
  25. Angiogenesis, vascular endothelial growth factor and the endometrium. Smith, S.K. Hum. Reprod. Update (1998) [Pubmed]
  26. Progression of cervical intraepithelial neoplasia to cervical cancer: interactions of cytochrome P450 CYP2D6 EM and glutathione s-transferase GSTM1 null genotypes and cigarette smoking. Warwick, A.P., Redman, C.W., Jones, P.W., Fryer, A.A., Gilford, J., Alldersea, J., Strange, R.C. Br. J. Cancer (1994) [Pubmed]
  27. Nitric oxide synthase expression and steroid regulation in the uterus of women with menorrhagia. Zervou, S., Klentzeris, L.D., Old, R.W. Mol. Hum. Reprod. (1999) [Pubmed]
  28. Microvascular density, vascular endothelial growth factor A, and its receptors in endometrial blood vessels in patients with menorrhagia. Mints, M., Blomgren, B., Falconer, C., Fianu-Jonasson, A., Palmblad, J. Fertil. Steril. (2005) [Pubmed]
  29. A double-blind trial of ethamsylate in the treatment of primary and intrauterine-device menorrhagia. Harrison, R.F., Cambell, S. Lancet (1976) [Pubmed]
  30. Clinical application of inhibitors of fibrinolysis. Verstraete, M. Drugs (1985) [Pubmed]
  31. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding. Hickey, M., Fraser, I.S. Hum. Reprod. (2002) [Pubmed]
  32. Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation. Amsterdam, A., Jakubowski, A., Castro-Malaspina, H., Baxi, E., Kauff, N., Krychman, M., Stier, E., Castiel, M. Bone Marrow Transplant. (2004) [Pubmed]
  33. Short and medium term outcomes after rollerball endometrial ablation for menorrhagia. Fraser, I.S., Angsuwathana, S., Mahmoud, F., Yezerski, S. Med. J. Aust. (1993) [Pubmed]
WikiGenes - Universities